î
îŒ
î
PolyPid Ltd
PYPD3.970USD
+0.050+1.28%
çµå€Â 12/19, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
66.04Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± PolyPid Ltd äŒæ¥å
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
PolyPid Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãPYPD
äŒç€ŸåPolyPid Ltd
äžå Žæ¥Jun 26, 2020
æé«çµå¶è²¬ä»»è
ãCEOãAkselbrad (Dikla Czaczkes)
åŸæ¥å¡æ°57
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jun 26
æ¬ç€Ÿæåšå°18 Hasivim Street, P.O Box 7126
éœåžPETAH TIKVA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·4917002
é»è©±çªå·972747195700
ãŠã§ããµã€ãhttps://www.polypid.com
äŒæ¥ã³ãŒãPYPD
äžå Žæ¥Jun 26, 2020
æé«çµå¶è²¬ä»»è
ãCEOãAkselbrad (Dikla Czaczkes)
PolyPid Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
+100.00%
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Mr. Chaim Hurvitz
Mr. Chaim Hurvitz
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Robert Burton (Bob) Stein, M.D., Ph.D.
Dr. Robert Burton (Bob) Stein, M.D., Ph.D.
Independent Director
Independent Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
+100.00%
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Mr. Chaim Hurvitz
Mr. Chaim Hurvitz
Independent Director
Independent Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Mon, Nov 17
æŽæ°æå»: Mon, Nov 17
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Aurum Ventures M.K.I.
18.53%
Centaurus Investments Limited
6.66%
Rosalind Advisors, Inc.
5.52%
AIGH Capital Management, LLC.
4.64%
Nir (Yehuda)
3.69%
ä»ã®
60.96%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Aurum Ventures M.K.I.
18.53%
Centaurus Investments Limited
6.66%
Rosalind Advisors, Inc.
5.52%
AIGH Capital Management, LLC.
4.64%
Nir (Yehuda)
3.69%
ä»ã®
60.96%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Venture Capital
18.66%
Hedge Fund
10.77%
Holding Company
6.66%
Individual Investor
5.52%
Private Equity
4.64%
Corporation
3.53%
Investment Advisor/Hedge Fund
1.76%
Research Firm
1.36%
Investment Advisor
1.22%
ä»ã®
45.87%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Oct 1
æŽæ°æå»: Wed, Oct 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
28
6.76M
43.18%
+2.23M
2025Q2
41
7.60M
74.58%
+1.39M
2025Q1
42
7.66M
75.16%
+942.60K
2024Q4
44
5.48M
65.20%
+1.87M
2024Q3
50
4.47M
69.98%
+1.49M
2024Q2
58
3.43M
73.51%
+1.59M
2024Q1
59
3.33M
71.29%
+2.56M
2023Q4
54
443.78K
34.10%
+80.67K
2023Q3
57
479.04K
37.01%
+97.48K
2023Q2
57
472.86K
36.65%
+91.51K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Aurum Ventures M.K.I.
3.08M
19.69%
+1.06M
+52.19%
Jun 30, 2025
Centaurus Investments Limited
1.11M
7.08%
+475.10K
+75.12%
Dec 31, 2024
Rosalind Advisors, Inc.
975.46K
6.23%
-42.56K
-4.18%
Jun 30, 2025
AIGH Capital Management, LLC.
462.54K
2.95%
-48.41K
-9.47%
Jun 30, 2025
Nir (Yehuda)
613.91K
3.92%
+62.60K
+11.36%
Mar 31, 2025
Hewlett Fund, L.P.
587.92K
3.76%
+338.44K
+135.66%
Feb 26, 2025
Triple Gate Capital, LP
465.84K
2.98%
+465.84K
--
Feb 26, 2025
Lukach (Aharon)
299.55K
1.91%
-5.64K
-1.85%
Mar 31, 2025
Worth Venture Partners, LLC
731.57K
4.67%
+302.14K
+70.36%
Jun 30, 2025
Dafna Capital Management, LLC
207.90K
1.33%
-83.37K
-28.62%
Jun 30, 2025
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
Aug 30, 2023
Merger
30â1
Aug 30, 2023
Merger
30â1
Aug 30, 2023
Merger
30â1
Aug 30, 2023
Merger
30â1
æ¥ä»
çš®é¡
æ¯ç
Aug 30, 2023
Merger
30â1
Aug 30, 2023
Merger
30â1
Aug 30, 2023
Merger
30â1
Aug 30, 2023
Merger
30â1
ãããã質å
PolyPid Ltdã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îPolyPid Ltdã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
Aurum Ventures M.K.I.ã¯3.08Mæ ªãä¿æããŠãããããã¯å šäœã®19.69%ã«çžåœããŸãã
Centaurus Investments Limitedã¯1.11Mæ ªãä¿æããŠãããããã¯å šäœã®7.08%ã«çžåœããŸãã
Rosalind Advisors, Inc.ã¯975.46Kæ ªãä¿æããŠãããããã¯å šäœã®6.23%ã«çžåœããŸãã
AIGH Capital Management, LLC.ã¯462.54Kæ ªãä¿æããŠãããããã¯å šäœã®2.95%ã«çžåœããŸãã
Nir (Yehuda)ã¯613.91Kæ ªãä¿æããŠãããããã¯å šäœã®3.92%ã«çžåœããŸãã
Aurum Ventures M.K.I.ã¯3.08Mæ ªãä¿æããŠãããããã¯å šäœã®19.69%ã«çžåœããŸãã
Centaurus Investments Limitedã¯1.11Mæ ªãä¿æããŠãããããã¯å šäœã®7.08%ã«çžåœããŸãã
Rosalind Advisors, Inc.ã¯975.46Kæ ªãä¿æããŠãããããã¯å šäœã®6.23%ã«çžåœããŸãã
AIGH Capital Management, LLC.ã¯462.54Kæ ªãä¿æããŠãããããã¯å šäœã®2.95%ã«çžåœããŸãã
Nir (Yehuda)ã¯613.91Kæ ªãä¿æããŠãããããã¯å šäœã®3.92%ã«çžåœããŸãã
PolyPid Ltdã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îPolyPid Ltdã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
Aurum Ventures M.K.I.
Centaurus Investments Limited
Rosalind Advisors, Inc.
Aurum Ventures M.K.I.
Centaurus Investments Limited
Rosalind Advisors, Inc.
PolyPid LtdïŒPYPDïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q3æç¹ã§ãPolyPid Ltdã®æ ªåŒãä¿æããŠããæ©é¢ã¯28瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ6.76Mã§ãå
šäœã®43.18%ãå ããŠããŸãã2025Q2ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-31.40%å¢å ããŠããŸãã
PolyPid Ltdã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéãPolyPid Ltdã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
